7 killed, 14 injured in suicide blast outside Pak court

February 21, 2017

Peshawar, Feb 21: At least seven persons were killed and 14 injured in a suicide blast and firing by terrorists outside a court in Pakistan's Khyber Pakhtunkhwa province today. Security forces killed three suicide attackers outside the court in Khyber Pakhtunkhwa's Charsadda district, police said.

pak

The three attackers attempted to enter the court premises in Tangi town through the main gate. They opened fire and threw grenades, prompting retaliatory fire by security forces deployed there. One bomber was killed in the firing at the gate and the second was killed as he entered the court. The third bomber died when he detonated his explosives, officials said.

Deputy Commissioner of Charsadda said judges and lawyers were safe. He said due to tight security the bombers could not enter the court, but had they been successful in entering the premises it "would have been a catastrophe". A search and rescue operation was underway, he added.

Ambulances have been rushed to Charsadda from Peshawar, approximately 30 kilometres away, where the Lady Reading Hospital has been put on high alert. The latest attack came as security has been tightened across Pakistan after a recent wave of terrorist strikes killed more than 100 people.

On Thursday, a suicide bomber killed 88 people at a famed Sufi shrine in Sindh province. Following the attack, the army launched an offesive against militants and claimed to have killed more than 130 terrorists across the country. A suicide bomber had struck a local court in Charsadda's Shabqadar area last year in March, killing 17 people.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 8,2024

covid.jpg

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.